Publication:
Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever

Simple item page
dc.contributor.kuauthorErgönül, Önder
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid110398
dc.date.accessioned2024-11-10T00:02:10Z
dc.date.issued2014
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.volume29
dc.identifier.doi10.1016/j.ijid.2014.08.016
dc.identifier.eissn1878-3511
dc.identifier.issn1201-9712
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-84916879563
dc.identifier.urihttp://dx.doi.org/10.1016/j.ijid.2014.08.016
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16079
dc.identifier.wos348023600064
dc.keywordsEfficacy
dc.keywordsImpact
dc.keywordsTurkey
dc.languageEnglish
dc.publisherElsevier Sci Ltd
dc.sourceInternational Journal of Infectious Diseases
dc.subjectInfectious diseases
dc.titleEvidence supports ribavirin use in Crimean-Congo hemorrhagic fever
dc.typeLetter
dspace.entity.typePublication
local.contributor.authorid0000-0003-1935-9235
local.contributor.kuauthorErgönül, Mehmet Önder

Files

Collections

Publications without Fulltext